- Home
- ATXG vs INM Comparison
ATXG vs INM Comparison
Compare ATXG & INM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATXG
- INM
- Stock Information
- Founded
- ATXG 2014
- INM 1981
- Country
- ATXG China
- INM Canada
- Employees
- ATXG N/A
- INM N/A
- Industry
- ATXG Professional Services
- INM Biotechnology: Pharmaceutical Preparations
- Sector
- ATXG Consumer Discretionary
- INM Health Care
- Exchange
- ATXG Nasdaq
- INM Nasdaq
- Market Cap
- ATXG 3.9M
- INM 3.4M
- IPO Year
- ATXG N/A
- INM N/A
- Fundamental
- Price
- ATXG $0.71
- INM $4.95
- Analyst Decision
- ATXG
- INM
- Analyst Count
- ATXG 0
- INM 0
- Target Price
- ATXG N/A
- INM N/A
- AVG Volume (30 Days)
- ATXG 34.8K
- INM 26.6K
- Earning Date
- ATXG 02-12-2025
- INM 02-11-2025
- Dividend Yield
- ATXG N/A
- INM N/A
- EPS Growth
- ATXG N/A
- INM N/A
- EPS
- ATXG N/A
- INM N/A
- Revenue
- ATXG $4,958,444.00
- INM $4,960,506.00
- Revenue This Year
- ATXG N/A
- INM N/A
- Revenue Next Year
- ATXG N/A
- INM N/A
- P/E Ratio
- ATXG N/A
- INM N/A
- Revenue Growth
- ATXG N/A
- INM 5.17
- 52 Week Low
- ATXG $0.49
- INM $2.42
- 52 Week High
- ATXG $1.77
- INM $15.70
- Technical
- Relative Strength Index (RSI)
- ATXG 54.07
- INM 55.90
- Support Level
- ATXG $0.58
- INM $4.07
- Resistance Level
- ATXG $0.78
- INM $5.41
- Average True Range (ATR)
- ATXG 0.10
- INM 0.39
- MACD
- ATXG -0.00
- INM 0.01
- Stochastic Oscillator
- ATXG 46.53
- INM 67.83
About ATXG Addentax Group Corp.
Addentax Group Corp is an investment holding company. The company through its operating subsidiaries functions in the following segments; Garment manufacturing; Logistics services; Property management and subleasing. It generates maximum revenue from the Logistics services segment which provides logistics services including storage, transportation, warehousing, handling, packaging, and order processing. It also provides customs declaration and tax clearance services to its customers who export goods overseas. Geographically, the company derives all of its revenue from China.
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.